🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate, in comparison with placebo, the efficacy o...
Status
Completed
Location
Investigational Site Number 8400006
Start Date
2016-12-21
Trial ID
NCT02921971
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
Prospective monocentric study, non-randomized of the detection of sarcopeni...
Status
Recruiting
Location
Centre Hospitalier Metropole Savoie
Start Date
2022-11-20
Trial ID
NCT05833321
Treatments Being Tested
Metabolic syndrome (Mets) is defined as the collection of risk factors cont...
Status
Completed
Location
Multiple Locations
Start Date
2017-01-01
Trial ID
NCT03265184
Treatments Being Tested
This is a phase 1, open-label, non-randomized study enrolling pediatric and...
Status
Recruiting
Location
Seattle Children's Hospital
Start Date
2024-12-16
Trial ID
NCT06465147
Treatments Being Tested
This program is a comprehensive evaluation of rheumatic valvular heart dise...
Status
Completed
Location
Princess Marina Hospital
Start Date
2016-08-22
Trial ID
NCT02832544
Treatments Being Tested
Myocarditis is a complex inflammatory disease, usually occurring secondary ...
Status
Recruiting
Location
IRCCS San Raffaele Scientific Institute
Start Date
2013-01-01
Trial ID
NCT06591260
To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT a...
Status
Withdrawn
Location
Wills Eye Institute
Start Date
2015-08-24
Trial ID
NCT02563782
This was a multicenter, randomized, double-blind, phase III trial. This cli...
Status
Completed
Location
Jiangsu hengrui medicine CO. LTD
Start Date
2014-03-26
Trial ID
NCT02329860